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Abstract
Background: Cytokines such as interleukin 1β (IL-1β) have been implicated in the development
of central sensitization that is characteristic of neuropathic pain. To examine its long-term effect
on nociceptive processing, defined medium organotypic cultures of rat spinal cord were exposed
to 100 pM IL-1β for 6–8 d. Interleukin effects in the dorsal horn were examined by whole-cell
patch-clamp recording and Ca2+ imaging techniques.
Results: Examination of the cultures with confocal Fluo-4 AM imaging showed that IL-1β increased
the change in intracellular Ca2+ produced by exposure to 35–50 mM K+. This is consistent with a
modest increase in overall dorsal horn excitability. Despite this, IL-1β did not have a direct effect
on rheobase or resting membrane potential nor did it selectively destroy any specific neuronal
population. All effects were instead confined to changes in synaptic transmission. A variety of pre-
and postsynaptic actions of IL-1β were seen in five different electrophysiologically-defined neuronal
phenotypes. In putative excitatory 'delay' neurons, cytokine treatment increased the amplitude of
spontaneous EPSC's (sEPSC) and decreased the frequency of spontaneous IPSC's (sIPSC). These
effects would be expected to increase dorsal horn excitability and to facilitate the transfer of
nociceptive information. However, other actions of IL-1β included disinhibition of putative
inhibitory 'tonic' neurons and an increase in the amplitude of sIPSC's in 'delay' neurons.
Conclusion: Since spinal microglial activation peaks between 3 and 7 days after the initiation of
chronic peripheral nerve injury and these cells release IL-1β at this time, our findings define some
of the neurophysiological mechanisms whereby nerve-injury induced release of IL-1β may
contribute to the central sensitization associated with chronic neuropathic pain.
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Background
Chronic, intractable neuropathic pain is a major clinical
problem. It is initiated by nerve, brain or spinal injury or
by complications associated with diseases such as post-
herpetic neuralgia, stroke or diabetes. Much of our under-
standing of the underlying pathophysiology comes from
animal models in which experimentally-induced periph-
eral nerve damage initiates behaviors analogous to the
symptoms of human neuropathic pain [1,2]. Manipula-
tions such as sciatic chronic constriction injury (CCI) pro-
duce aberrant spontaneous activity in primary afferent
fibers [3]. This promotes the release of various 'pain medi-
ators' both from primary afferent terminals and activated
spinal microglia [4]. These mediators promote an endur-
ing increase in dorsal horn excitability that underlies the
'central sensitization' which characterizes neuropathic
pain.
The cytokine, interleukin 1β (IL-1β) is of special interest
in this regard as it is secreted under conditions associated
with pain and hyperalgesia [5-7] and is elevated in the cer-
ebral spinal fluid of chronic pain patients [8]. In mice,
neutralizing antibodies to interleukin 1-receptor reduce
pain behavior associated with experimental neuropathy
[9]. Moreover, deletion of IL-1 receptor type 1 or trans-
genic overexpression of the naturally occurring IL-1 recep-
tor antagonist (IL-1RA) delay the onset and severity of
pain associated with peripheral nerve injury [10]. Similar
effects are seen in animals lacking the IL-1β gene [11,12].
The matrix metalloproteases, MMP9 and MMP2 have
recently been implicated in the onset and maintenance of
neuropathic pain [13] and IL-1β identified as a vital
downstream effector of their action. It has also been
reported that the frequency and amplitude of spontane-
ous EPSC's (sEPSC) is increased and the frequency and
amplitude of spontaneous IPSC's (sIPSCs) is decreased
following a 4 min application of 600 pM IL-1β to neurons
in the superficial dorsal horn [14]. Although these find-
ings provide information on the acute spinal actions of a
relatively high concentration of IL-1β [15], this methodol-
ogy may not be appropriate for understanding the role of
interleukins in central sensitization. There are three rea-
sons for this:
First, in Sprague Dawley rats, spinal microglial activation
in response to peripheral nerve injury peaks between days
3 and 7 and returns to normal after about 28 days [4,16]
and IL-1β levels continue to increase for at least 35 days
[17]. It is likely that microglial-derived IL-1β is involved in
the induction phase of central sensitization whereas the
maintenance of sensitization may involve astrocyte –
derived interleukin [18]. This means that spinal neurons
in vivo are exposed to elevated interleukin levels for several
weeks following nerve injury. It is therefore questionable
whether their response to an acute, transient application
of IL-1β [14] is relevant to the process of pain centraliza-
tion which takes days or weeks to develop. This is of par-
ticular concern because the neuronal actions of IL-1β are
time-dependent. For example, acute (5 min) application
of IL-1β reduces Na+ channel currents in primary afferent
neurons whereas longer-term (24 h) application has the
opposite effect; it increases the current [19]. This latter
effect likely involves altered gene expression [20].
Second, random sampling of superficial dorsal horn neu-
rons with patch electrodes reveals that >30% of neurons
exhibit a 'tonic' discharge pattern [21], that has been asso-
ciated with inhibitory interneurons [22]. It is likely there-
fore that some of the reported acute excitatory actions of
IL-1β [14] were exerted on inhibitory interneurons. This
would produce an overall dampening of dorsal horn
excitability that would be inconsistent with the proposed
role of IL-1β in central sensitization.
Third, freshly isolated spinal cord slices, as used in a pre-
vious study of cytokine action [14], are likely to be under-
going an acute inflammatory response associated with
microglia activation. Substances released from activated
microglia might affect neuronal responses to exoge-
nously-applied cytokine.
To address these issues and to provide additional infor-
mation on neurophysiological mechanisms by which IL-
1β produces a slowly developing increase in spinal cord
excitability, we examined the effect of long-term (6–8 d)
exposure of spinal neurons to IL-1β. Experiments were
done using a defined medium organotypic culture system
developed in our laboratory [23,24].
We found that IL-1β did not selectively destroy any spe-
cific neuronal population, nor did it have a direct effect on
postsynaptic membrane excitability. Its actions were
instead confined to changes in synaptic transmission.
These changes were not homogeneous throughout the
whole neuronal population as different effects were seen
on putative inhibitory and excitatory neurons. Because
overall dorsal horn excitability appeared to increase, pro-
nociceptive/excitatory effects likely dominated over inhib-
itory/antinociceptive effects. These findings define some
of the long-term neurophysiological mechanisms
whereby nerve-injury induced release of IL-1β may con-
tribute to the central sensitization associated with chronic
neuropathic pain.
Methods
All experimental procedures were approved by the Univer-
sity of Alberta Health Sciences Laboratory Animal Policy
and Welfare Committee.Molecular Pain 2008, 4:63 http://www.molecularpain.com/content/4/1/63
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Organotypic Cultures
Defined medium organotypic cultures of prenatal
Sprague-Dawley rat spinal cord were prepared as
described previously using a roller drum technique
[23,24] The schedule of medium changes is depicted sche-
matically in Fig 1A. Cultures were maintained until the
neurons therein attained an age comparable to those in
the juvenile rats in which we studied the effects of sciatic
chronic constriction injury (CCI) [21,24] (Fig 1B see dis-
cussion). Slices were superfused at ~22°C with 95%O2-
5% CO2 saturated artificial cerebrospinal fluid which con-
tained (in mM): 127 NaCl, 2.5 KCl, 1.2 NaH4GO4, 26
NaHCO3, 1.3 MgSO4, 2.5 CaCl2, 25 D-glucose, pH 7.4
(320–325 mOsm). IL-1β (Calbiochem, Hornby, ON,
A. Time course of media exchanges in spinal cord organotypic cultures, establishment of defined medium and time course of  IL-1β application Figure 1
A. Time course of media exchanges in spinal cord organotypic cultures, establishment of defined medium and 
time course of IL-1β application. Nerve Growth Factor (NGF) was 20 ng/ml. Serum was progressively removed by succes-
sive dilutions during exchanges of medium. Pen/Strep/Amp = 5 units/mL penicillin G, 5 units/mL streptomycin, and 12.5 ng/mL 
amphotericin B, Ara-C/U/5 FDU = uridine, cytosine-β-D-arabino-furanoside (AraC), and 5-fluorodeoxyuridine (all at 10 μM). 
B. Comparison of time course of present IL-1β studies with previous studies of sciatic chronic constriction injury (CCI) [21]. 
Time scale in days refers to age of experimental animals. C. Photomicrograph obtained from an acutely isolated spinal cord 
slice. The central canal appears as the light area just to the right of the upper centre of the picture. The ventral surface of the 
cord is to the left D. Photomicrograph obtained from an organotypic culture, Sections in C and D both immuno-reacted for 
the microglial marker Iba-1. Calibration bar in both plates is 50 μm.
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Canada) treatments were initiated 14 to 28 d after the start
of culture. Serum-free medium containing IL1-β was
exchanged 4 d thereafter and recordings made on days 6–
8. IL-1β stocks, dissolved in bovine serum albumin (BSA)
were diluted in medium containing 0.1% BSA. The con-
trol group contained the same amount of BSA as the IL-1β
group.
Acute spinal cord slices, Iba-1 staining and IL-1b 
Measurements
Acute spinal cord slices were prepared from 20–40 d male
Sprague-Dawley rats as previously described [21]. These,
as well as organotypically cultured slices, were fixed in
10% formalin solution for 5 minutes Fixed slices were
then incubated for 30 mins in a blocking solution con-
taining 10% horse serum, 0.03% hydrogen peroxide and
2.5% Triton in PBS. After blocking, the slices were incu-
bated in a primary antibody solution containing 1:1000
anti-Iba1 (Wako, #01-1974) which labels microglia, 1%
horse serum, and 2.5% Triton in PBS at 4°C overnight.
The slices were then washed and incubated with the sec-
ondary antibody, 1:200 biotinylated IgG 1:200 (Serotec),
for 30 minutes followed by further washings and incuba-
tion with HRP-conjugated-strepavidin (1:200, Vector
Labs., Burlingame, CA, USA) for 30 minutes (both were
diluted in PBS containing 1% horse serum). The labeling
was visualized using diaminobenzidine-hydrogen perox-
ide (Sigma). IL-1β ELISA kits (R&D systems) were
obtained from Cedarlane Laboratories, Burlington, ON,
Canada and ELISA procedures carried out according to the
manufacturer's protocol.
Electrophysiology
Whole-cell recordings were made under infrared differen-
tial interference contrast optics. Neurons chosen for
recording were located 0.5 – 2 mm from the dorsal surface
of the slices [23,24]. Data were acquired from neurons
that exhibited action potentials > 65 mV in amplitude and
were analyzed using pCLAMP 9.0 (Molecular Devices,
Burlingame, CA, USA). The solution in patch pipettes con-
tained (in mM): 130 D-gluconic acid, 2 CaCl2, 10 HEPES,
10 EGTA, 4 Mg-ATP, 0.3 Na-GTP, 0.2% Biocytin, adjusted
to pH 7.2 with KOH (290–300 mOsm). Spontaneous
EPSC's (sEPSC) were recorded at -70 mV and spontaneous
IPSC's (sIPSC) at 0 mV. Mini Analysis Program (Synap-
tosoft, Decatur, GA, USA) was used to prepare cumulative
probability plots. Up to 100 spontaneous synaptic events
from each neuron were used for analysis (up to 200
sIPSC's were analyzed in delay neurons). Cumulative
probability plots and bar graphs were constructed for data
from 4 to 8 neurons. This meant that similar total num-
bers of events were sampled from each neuron type in the
control and IL-1β treated groups. As in our previous work,
both t-tests of means ± SE and the Kolmogorov-Smirnov
two-sample test (K-S test) were used to compare distribu-
tions of amplitudes and inter-event intervals of synaptic
events in the control and experimental situations
[21,23,24]. Distributions were considered statistically sig-
nificant if p < 0.05.
Confocal Ca2+ Imaging
Cultures were challenged with 20, 35 or 50 mM K+ and the
resulting elevation of intracellular Ca2+  concentration
used as an index of overall increase in excitability. Ca2+
imaging was carried out as described previously [24,25]
using Fluo-4 AM (TEF Labs Inc. Austin, Texas, USA). Fluo-
rescence signals were visualized with a confocal micro-
scope equipped with an argon (488 nm) laser and filters
(20× XLUMPlanF1-NA-0.95 objective; Olympus FV300,
Carsen group, Markham, Ontario, Canada). Image files
were stored on disk for off-line analysis. Selected regions
of interest were drawn around distinct cell bodies and
traces of time course of change of fluorescence intensity
were generated with FluoView v.4.3 (Olympus). Neurons
out of the plane of focus were rejected for analysis and
data only collected from those that responded reversibly
to a high K+ challenge. Data were collected from 4–10
neurons per culture.
Results
Microglial status in acute and organoypically-cultured 
spinal cord slices
Removal and transverse sectioning of the spinal cord to
prepare acute spinal cord slices would be expected to pro-
duce profound microglial activation. To verify this, we
used a marker for the microglial-specific calcium binding
protein, Iba1 [26]. Although this protein is present in rest-
ing microglia, it is upregulated when they are activated
[27]. Fig 1C shows numerous rod-shaped, amoeboid and
round cells positive for Iba-1 indicating microglia/macro-
phages at various stages of activation in an acutely isolated
spinal cord slice. This slice was fixed approximately 80
min after removal from the animal and subject to the nor-
mal isolation and stabilization processes used in our
whole-cell recording protocol [21]. By contrast, the orga-
notypic section displayed in Fig 1D shows very few
immuno-positive cells suggesting little microglial/macro-
phage activation.
IL-1β Alters Overall Network Excitability
Measured concentrations of IL-1β in dorsal root ganglia or
spinal cord of rats exhibiting injury-related pain range
from 60 pM [28] to 3 nM [13]. A standard ELISA for IL-1β
revealed that the resting concentration of IL-1β in our con-
trol cultures was between 4 and 20 pM. We therefore
elected to apply cytokine at 100 pM, this yielded a final
concentration of 120 pM in the culture medium (as meas-
ured by ELISA).Molecular Pain 2008, 4:63 http://www.molecularpain.com/content/4/1/63
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Peripheral nerve injury increases the rate of spontaneous
and 'pinch-evoked' action potential discharge in the dor-
sal horn in vivo [29]. This presumably reflects altered syn-
aptic transmission [21] and perhaps changes in intrinsic
neuronal properties. If IL-1β is involved in central sensiti-
zation, it should increase the tendency for the cultures to
generate action potentials. Since action potential activity
promotes an increase in intraneuronal Ca2+, the Ca2+
response to a depolarizing stimulus can be used as an
index of the overall excitability of a neuronal network.
Thus, to test whether 6–8 d treatment with 100 pM IL-1β
increased overall excitability of the dorsal horn, cultures
were challenged with 20, 35 and 50 mM K+ and the result-
ing increases in intracellular [Ca2+] monitored using con-
focal Fluo-4-AM Ca2+ imaging. Twenty-six cells from slices
in each condition were analyzed, and both the amplitude
and area under the curve (AUC) of the K+-induced fluores-
cence intensity increase were measured. Figure 2A shows
fluorescence signals selected from various regions of inter-
est (four neurons selected as per methods section) in
response to a 20 mM K+ challenge. With respect to signal
amplitude, it was found that the response to 50 mM K+ in
IL-1β-treated neurons was significantly greater than that
of controls (p = 0.02, Fig 2B). Similarly, the area under the
curve of the responses to 35 mM and 50 mM K+ (Fig 2C)
was significantly greater in IL-1β-treated cells than in con-
trols (p < 0.01 and <0.001, respectively). This suggests that
6–8 d treatment with 100 pM IL-1β produces a modest
increase in overall excitability.
IL-1β does not affect postsynaptic membrane properties
We have shown previously that the region of organotypic
cultures that was selected for recording [23,24] contains
the same five neuronal types that are found in the substan-
Effects of 6–8 d exposure of the dorsal hornregion of organotypic cultures to 100 pM IL-1β A. Typical time courses of changes  in Fluo 4-AM fluorescence, indicating changes in free intracellular [Ca2+] in response to raising [K+] in superfusate from 2.5 to  20 mM Figure 2
Effects of 6–8 d exposure of the dorsal hornregion of organotypic cultures to 100 pM IL-1β A. Typical time 
courses of changes in Fluo 4-AM fluorescence, indicating changes in free intracellular [Ca2+] in response to 
raising [K+] in superfusate from 2.5 to 20 mM. Traces are recordings from somata of cells marked as regions of interest 
for the analysis software. B and C. Quantification of Fluo-4 fluorescence changes in response to 20, 35 and 50 mM K+ from 26 
control and 26 IL-1β treated neurons. Changes in amplitude in response to 50 mM K+ are increased in cytokine-treated slices 
(p = 0.02). For area under curve (AUC) significant increases are seen for both 35 mM (p < 0.01) and 50 mM K+ (p < 0.001).
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tia gelatinosa of acutely isolated slices of rat spinal cord
[21]. On the basis of their discharge pattern in response to
depolarizing current, these are described as tonic, delay,
irregular, phasic and transient (Fig 3A–3E). The relative
proportion of each cell type stabilizes after about 20 d in
culture [23] and this was unaffected by IL-β treatment (Fig
3F, for all groups χ2 > 0.2). The resting membrane poten-
tial and rheobase of all five cell types were also unchanged
(p values ranged from 0.12 to 0.99, Table 1).
Effects of IL-1β on synaptic transmission
IL-1β did not produce a generalized increase or decrease
in synaptic transmission but rather caused a series of neu-
ron-type selective changes. Effects on the amplitude and
interevent interval of sEPSCs and sIPSCs were analyzed
for tonic and delay cells. This is because inhibitory
interneurons often exhibit a tonic discharge pattern
[22,30] whereas delay neurons may be excitatory [31].
Effects of IL-1β on sEPSC's and sIPSC's were analyzed in
two ways. First, mean values of amplitude and interevent
intervals were compared by means of a t-test. Data for
tonic and delay cells are shown in Fig 4A–4D. Second, the
same data sets were re-plotted as cumulative probabilities
(Fig 4E–4L) and compared using the K-S test. The follow-
ing effects of IL-1β were significant according to both anal-
yses:-
1. An increase in the amplitude of sEPSC's (Fig 4A and 4I)
and an increase in the interevent interval (decreased fre-
A – E. Illustrations of discharge pattern of tonic, delay, irregular, phasic and transient neurons in organotypic culture in  response to current commands as illustrated Figure 3
A – E. Illustrations of discharge pattern of tonic, delay, irregular, phasic and transient neurons in organotypic 
culture in response to current commands as illustrated. Membrane potential was set to -60 mV. F. Comparison of the 
percentages of these 5 neuronal types in control (BSA) and cytokine-treated cultures Data from 48 control neurons and 35 
interleukin-treated neurons. Numbers over each column refer to number of cells in each category.
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quency) of sIPSC's in delay neurons (Fig 4D and 4L).
These actions would be expected to augment synaptic
drive to putative excitatory neurons. This would tend to
increase overall excitability and to facilitate the transfer of
nociceptive information.
2. Large increases in the amplitude of sIPSC's in delay neu-
rons (Fig 4C and 4K) and increases in the interevent inter-
val (decreased frequency) of sIPSC's in tonic neurons (Fig
4D and 4H). Increased inhibition of excitatory cells and
disinhibition of inhibitory cells might be expected to
reduce overall network excitability.
Sample recordings of sEPSC's at -70 mV and sIPSC's at 0
mV are shown in Figs 4M and 4N.
Discussion
Spinal microglial activation in response to peripheral
nerve injury peaks between days 3 and 7 and returns to
normal after about 28 days [4,16] whereas IL-1β levels
continue to increase for at least 35 days [17]. Since it is
impractical to apply interleukin for this length of time, we
opted to apply IL-1β for 6–8 d as as this would still allow
us to observe changes resulting from altered gene expres-
sion. Data from Ca2+ imaging (Fig 2A–2C) show that 6–8
d exposure to 100 pM IL-1β produces a modest increase in
spinal cord excitability. This does not appear to reflect
excitotoxic death of inhibitory neurons [32] as compara-
ble numbers of tonic neurons were seen in control and in
IL-1β treated slices (Fig 3F). Although there is evidence
that 24 h exposure of primary afferent neurons to IL-1β
increases excitability by an action on Na+ channels [19],
such changes are unlikely to occur following 6–8 d expo-
sure of neurons in the superficial dorsal horn as rheobase
was unaffected (Table 1). Since IL-1β promoted clear neu-
ron-type specific alterations in synaptic transmission, it is
likely that the modest increase in overall excitability
reflected an alteration in the balance of actions of excita-
tory and inhibitory neurotransmitters.
Effects of IL-1β on inhibitory synaptic transmission
Acute application of IL-1β potentiates the action of GABA
in amygdala [33] and hippocampus [34] yet reduces
sIPSC amplitude and GABA sensitivity in the superficial
dorsal horn [14]. Acute interleukin application also acts
presynaptically in amygdala to reduce neurotransmitter
release [33]. This may perhaps reflect suppression of Ca2+
channel conductance [35] in presynaptic terminals. It is
difficult to relate these results to ours, as to the best of
knowledge, only one other study of the long-term neuro-
physiological actions IL-1β on central neurons has
appeared [36]. The observed increase in interevent inter-
val of sIPSC's (Fig 4D, 4H and 4L) in both tonic and delay
cells suggests that some long-term actions of IL-1β at
inhibitory synapses are mediated presynaptically. It
remains to be determined whether this reflects retraction
of inhibitory synapses, a direct action on the neurotrans-
mitter release process, an action on presynaptic Ca2+ chan-
nels, a change in discharge frequency of presynaptic
action potentials or an alteration in the ability of the ter-
minals to release neurotransmitter.
The increase in sIPSC amplitude in delay cells (Figs 4C
and 4K) seen with long-term application of IL-1β is in
direct contrast to its aforementioned acute effect on uni-
dentified dorsal horn neurons where sIPSC amplitude is
decreased [14]. It is however similar to the long-term
action of IL-1β in organotypically cultured hippocampal
neurons [36]. Differences in the spinal actions may reflect
both the time course and the concentration of applied
interleukin. We used 100 pM IL-1β in our long term exper-
iments whereas others examined the acute actions of 600
pM (10 ng/ml) cytokine [14]. This concentration differ-
ence may be important because the neuronal effects of
Table 1: Effects of IL-1β on Resting Membrane Potential (RMP) and Rheobase in five electrophysiologically defined neuron types in 
organotypic cultures of rat spinal cord.
Tonic Delay Irregular Transient Phasic
RMP (mV) -52.5 ± 2.6 -48.6 ± 5.9 -51.3 ± 1.8 -45.0 ± 5.2 -56.3 ± 4.1
BSA Controls n = 11 n = 5 n = 23 n = 5 n = 4
RMP (mV) -53.2 ± 4.6 -54.6 ± 3.7 -53.6 ± 1.9 -45.0 ± 5.4 -44.0 ± 4.6
100 pM IL-1β n = 6 n = 8 n = 14 n = 4 n = 3
Rheobase (pA) 25.0 ± 2.0 61.0 ± 20.0 82.5 ± 12.1 135.0 ± 32.9 118.8 ± 53.2
BSA Controls n = 9 n = 5 n = 18 n = 4 n = 4
Rheobase (pA) 31.7 ± 10.1 72.1 ± 8.4 70.8 ± 11.9 173.8 ± 65.9 105.0 ± 20.0
100 pM IL-1β n = 6 n = 7 n = 12 n = 4 n = 2
Data expressed as Means ± SE. p values ranged from 0.12 to 0.99Molecular Pain 2008, 4:63 http://www.molecularpain.com/content/4/1/63
Page 8 of 11
(page number not for citation purposes)
A – D. Bar graphs illustrating effect of IL-1β on amplitude and interevent interval of sIPSC's and sEPSC's in tonic and delay cells Figure 4
A – D. Bar graphs illustrating effect of IL-1β on amplitude and interevent interval of sIPSC's and sEPSC's in 
tonic and delay cells. Error bars = S.E.M., graphs produced from same data as used for cumulative probability plots. E – L. 
Reanalysis of the data in A-D shown as cumulative probability plots. For EPSC's in tonic cells (E and F), 800 events from 8 neu-
rons analyzed in control (minimum # of events analyzed per cell = 100), 563 events from 6 neurons analyzed in IL-1β (mini-
mum # of events analysed per cell = 63); For IPSC's in tonic cells (G and H), 600 events from 6 neurons analyzed in control 
(minimum # of events analyzed per cell = 100), 239 events analyzed in 5 neurons in IL-1β (minimum # of events analysed per 
cell = 37); For EPSC's in delay cells (I and J), 699 events analyzed in 7 control neurons (minimum # of events analysed per cell 
= 99), 500 events analyzed in five neurons in IL-1β (minimum # of events analyzed per cell = 100); For IPSC's in delay cells (K 
and L), 751 events analyzed in 4 control neurons (minimum # of events analysed per cell = 151), 1085 events analyzed in 6 
neurons in IL-1β (minimum # of events analysed per cell = 85). M and N. Sample recordings of sEPSCs at -70 mV and sIPSC's 
at 0 mV.
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'physiological' concentrations of IL-1β differ from those
seen with 'toxic' or 'pharmacological' concentrations [15].
Effects of IL-1β on excitatory synaptic transmission
Acute applicationof IL-1β has been reported to increase
current through AMPA and NMDA receptor-channels and
to increase intracellular calcium levels [14,37], it may
therefore activate a postsynaptic process akin to long-term
potentiation. The increase in sEPSC amplitude that we
saw in delay cells (Fig 4A and 4I) could reflect persistence
of this acute effect with prolonged IL-1β application.
By contrast, acute (2 min) application of IL-1β has been
reported to increase sEPSC frequency in unidentified neu-
rons in the superficial dorsal horn [14]. This effect pre-
sumably abates during long-term interleukin application
as we saw no appreciable increase in sEPSC frequency
(decrease in interevent interval) in either tonic or delay
neurons. In fact, an increase in the mean interevent inter-
val in tonic cells was seen (Fig 4B) but this was not at all
significant according to the K-S test (P < 0.4 Fig 4F). There
was also a increase in interevent interval in delay cells but
this was barely significant according to the K-S test (P <
0.04, Fig 4J) and not significant according to the T-test
(Fig 4B). A conservative interpretation of these results is
that the effects of long-term IL-1β application on sEPSC
frequency (Figs 4B, 4F and 4J) play only a small role in
determining overall spinal cord excitability.
Relative importance of inhibitory and excitatory actions
Although the correlation between tonic firing cells and
inhibitory function and delay firing cells and excitation is
not absolute, several observations support this generaliza-
tion. For example, studies using a transgenic mouse strain
co-expressing enhanced green fluorescent protein and
GAD-67 associated the GABA phenotype with initial burst
(phasic), gap (irregular) or tonic and not with delay firing
patterns [38]. Also, tonic cells often exhibit an 'islet cell'
morphology [31] and many islet cells are inhibitory [30].
By contrast, paired recordings in substantia gelatinosa have
shown that intracellular stimulation of delay firing cells
produces excitatory events in postsynaptic neurons [39].
Thus, the IL-1β-induced increase in sEPSC amplitude and
the observed decrease in sIPSC frequency in delay neurons
(Fig 4A,4D,4I and 4L) would be expected to increase over-
all dorsal horn excitability. By contrast, the increase in
sIPSC amplitude in delay cells (Fig 4C and 4K) implies
increased inhibition of putative excitatory neurons. The
decreased frequency of sIPSC's in tonic cells (Fig 4D and
4H) would lead to disinhibition of putative inhibitory
neurons. Both would be expected to decrease overall dor-
sal horn excitability. Data from the Ca2+ imaging experi-
ments (Fig 2A–2C) suggest however that excitatory
actions dominate as there is a modest increase in overall
network activity. It is also likely that changes in synaptic
excitation of irregular, phasic and transient neurons con-
tribute to the overall effect of IL-1β. This possibility is dif-
ficult to address until much more is known about
substantia gelatinosa circuitry and the neurotransmitter
phenotype of irregular, phasic and transient cells is deter-
mined.
Use of organotypic cultures to study long-term IL-1β 
effects
As shown in Fig 1B, our experiments with organotypic cul-
ture were designed to mimic in vitro the effects of CCI in
vivo [21]. Because of the longevity of the cultures [23], we
were able to approximate the duration of cytokine expo-
sure to the time course of microglial activation reported
under these circumstances [4]. There has been some dis-
cussion as to whether the 20 d rats we used in our in vivo
experiments [21] are a relevant model for central sensiti-
zation as rats of similar age fail to develop allodynia in
response to spared nerve injury [40]. In our experimental
situation however, rats subject to CCI displayed clear
hyperalgesia 5 d post injury and clear allodynia 14 d post
injury [21]. We therefore conclude that our treatment pro-
tocol for cultures with IL-1β (Fig 1B) is highly pertinent to
understanding the pathophysiology of central sensitiza-
tion in vivo.
Although neurons in our cultures exhibit the same range
of electrophysiological and morphological phenotypes as
those found in acute slices, spontaneous synaptic activity
is increased [23,24]. It may therefore be argued that there
is some developmental difference in the cultures com-
pared to neurons of similar age in intact animals.
Although this argument is difficult to dismiss, other stud-
ies of similar cultures have shown that they retain the
basic cytoarchitecture of the spinal segment from which
they are derived [41,42]. Moreover, the appearance of a
variety of developmental markers mirrors that seen in vivo
[43]. A further advantage of using the cultures is that there
is no detectable microglia activation at the time of IL-1β
application (Fig 1D compared to Fig 1C). the presence of
activated microglia in acutely isolated slices questions
their suitability for studies of cytokine action.
Conclusion
Our findings define some of the basic neurophysiological
consequences of long-term exposure of the spinal dorsal
horn to 1L-1β. At 100 pM, the cytokine neither promotes
death of any particular neuronal phenotype nor does it
directly affect membrane excitability. It promotes selective
and differential effects on pre- and postsynaptic processes
in inhibitory and excitatory neurons that lead to a modest
overall increase in dorsal horn excitability. These findings
show how IL-1β may contribute to the onset and mainte-
nance of the central sensitization that underlies neuro-
pathic pain.Molecular Pain 2008, 4:63 http://www.molecularpain.com/content/4/1/63
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